1-5 of 5
Sachie Wada, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases

Hiroki Mizumaki, MD, Shinsuke Takagi, MD PhD, Naoyuki Uchida, MD PhD, Sachie Wada, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Aya Nishida, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Atsushi Wake, MD PhD, Koji Izutsu, Shuichi Taniguchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5931.
https://doi.org/10.1182/blood.V124.21.5931.5931
Published: 2014
Journal Articles

Early Central Nervous System Complications after Allogeneic Stem Transplantation: A Single-Center Analysis of 723 Patients Including 456 Cord Blood Recipients

Kosei Kageyama, MD, Hisashi Yamamoto, MD, Mitsuhiro Yuasa, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Kazuya Ishiwata, MD, Shinsuke Takagi, MD PhD, Masanori Tsuji, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Naoyuki Uchida, MD PhD, Koji Izutsu, Atsushi Wake, MD PhD, Akiko Yoneyama, MD PhD, Shigeyoshi Makino, MD PhD, Shuichi Taniguchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2468.
https://doi.org/10.1182/blood.V124.21.2468.2468
Published: 2014
Journal Articles

Second Cord Blood Transplantation for Relapsed Myeloid Malignancies Following Allogeneic Transplantation – a Single Institute Analysis for 85 Recipients

Mitsuhiro Yuasa, MD, Hisashi Yamamoto, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Shinsuke Takagi, MD PhD, Masanori Tsuji, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Naoyuki Uchida, MD PhD, Koji Izutsu, Atsushi Wake, MD PhD, Akiko Yoneyama, MD PhD, Shigeyoshi Makino, MD PhD, Shuichi Taniguchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2565.
https://doi.org/10.1182/blood.V124.21.2565.2565
Published: 2014
Journal Articles

A Novel Reduced-Toxicity Myeloablative Conditioningusing Full-Dose Busulfan and Melphalan For Cord Blood Transplantation Provides Durable Engraftment and Remission Without Increasing Non-Relapse Mortality In Advanced Myeloid Malignancies

Hisashi Yamamoto, MD, Naoyuki Uchida, MD, PhD, Kousei Kageyama, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Hikari Ota, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Shinsuke Takagi, MD, Go Yamamoto, MD, PhD, Yuki Asano-Mori, MD, PhD, Koji Izutsu, MD, PhD, Atsushi Wake, MD, PhD, Shuichi Taniguchi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2042.
https://doi.org/10.1182/blood.V122.21.2042.2042
Published: 2013
Journal Articles

Infliximab Versus Rabbit Anti-Thymocyte Globulin As a Salvage Treatment For Steroid-Refractory Acute Graft-Versus-Host Disease After Reduced-Intensity Cord Blood Transplantation In Adults

Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Kousei Kageyama, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Hikari Ota, MD, Shinsuke Takagi, MD, Masanori Tsuji, MD, Go Yamamoto, MD, PhD, Yuki Asano-Mori, MD, PhD, Naoyuki Uchida, MD, PhD, Koji Izutsu, MD, PhD, Atsushi Wake, MD, PhD, Akiko Yoneyama, MD, PhD, Shigeyoshi Makino, MD, PhD, Shuichi Taniguchi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4592.
https://doi.org/10.1182/blood.V122.21.4592.4592
Published: 2013